Global Point-of-care Molecular Diagnostic Solution Market Research Report 2025(Status and Outlook)

March 2025 | 239 pages | ID: GFC11227A234EN
Bosson Research

Abstracts

Report Overview

Molecular diagnostics involves the analysis of genetic material (DNA or RNA) to detect specific pathogens, mutations, or genetic markers associated with diseases.

This report provides a deep insight into the global Point-of-care Molecular Diagnostic Solution market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Point-of-care Molecular Diagnostic Solution Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Point-of-care Molecular Diagnostic Solution market in any manner.

Global Point-of-care Molecular Diagnostic Solution Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Laboratories

F. Hoffmann-La Roche AG

Becton

Dickinson and Company

BioMerieux

Bio-Rad Laboratories

Inc.

Cepheid

Inc.

Danaher Corporation

Johnson and Johnson

Bayer Healthcare

Market Segmentation (by Type)

Assays & kits

Instruments & Analyzers

Software & Services

Market Segmentation (by Application)

Physicians’ Offices

Hospitals & ICUs

Research Institutes

Other End Users

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Point-of-care Molecular Diagnostic Solution Market
• Overview of the regional outlook of the Point-of-care Molecular Diagnostic Solution Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Point-of-care Molecular Diagnostic Solution Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Point-of-care Molecular Diagnostic Solution
1.2 Key Market Segments
  1.2.1 Point-of-care Molecular Diagnostic Solution Segment by Type
  1.2.2 Point-of-care Molecular Diagnostic Solution Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTIC SOLUTION MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Point-of-care Molecular Diagnostic Solution Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Point-of-care Molecular Diagnostic Solution Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTIC SOLUTION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Point-of-care Molecular Diagnostic Solution Product Life Cycle
3.3 Global Point-of-care Molecular Diagnostic Solution Sales by Manufacturers (2020-2025)
3.4 Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Manufacturers (2020-2025)
3.5 Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Point-of-care Molecular Diagnostic Solution Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Point-of-care Molecular Diagnostic Solution Manufacturing Sites, Area Served, Product Type
3.8 Point-of-care Molecular Diagnostic Solution Market Competitive Situation and Trends
  3.8.1 Point-of-care Molecular Diagnostic Solution Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Point-of-care Molecular Diagnostic Solution Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 POINT-OF-CARE MOLECULAR DIAGNOSTIC SOLUTION INDUSTRY CHAIN ANALYSIS

4.1 Point-of-care Molecular Diagnostic Solution Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF POINT-OF-CARE MOLECULAR DIAGNOSTIC SOLUTION MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Point-of-care Molecular Diagnostic Solution Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Point-of-care Molecular Diagnostic Solution Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTIC SOLUTION MARKET SALES BY REGION

6.1 Global Point-of-care Molecular Diagnostic Solution Sales by Region
  6.1.1 Global Point-of-care Molecular Diagnostic Solution Sales by Region
  6.1.2 Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Region
6.2 Global Point-of-care Molecular Diagnostic Solution Market Size by Region
  6.2.1 Global Point-of-care Molecular Diagnostic Solution Market Size by Region
  6.2.2 Global Point-of-care Molecular Diagnostic Solution Market Size Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Point-of-care Molecular Diagnostic Solution Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Type
7.3 North America Point-of-care Molecular Diagnostic Solution Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Type
8.3 Europe Point-of-care Molecular Diagnostic Solution Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type
9.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Point-of-care Molecular Diagnostic Solution Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Point-of-care Molecular Diagnostic Solution Market Size by Type
10.3 South America Point-of-care Molecular Diagnostic Solution Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Type
11.3 Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Application

12 POINT-OF-CARE MOLECULAR DIAGNOSTIC SOLUTION MARKET PRODUCTION BY REGION

12.1 Global Production of Point-of-care Molecular Diagnostic Solution by Region(2020-2025)
12.2 Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Region (2020-2025)
12.3 Global Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Point-of-care Molecular Diagnostic Solution Production
  12.4.1 North America Point-of-care Molecular Diagnostic Solution Production Growth Rate (2020-2025)
  12.4.2 North America Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Point-of-care Molecular Diagnostic Solution Production
  12.5.1 Europe Point-of-care Molecular Diagnostic Solution Production Growth Rate (2020-2025)
  12.5.2 Europe Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Point-of-care Molecular Diagnostic Solution Production (2020-2025)
  12.6.1 Japan Point-of-care Molecular Diagnostic Solution Production Growth Rate (2020-2025)
  12.6.2 Japan Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Point-of-care Molecular Diagnostic Solution Production (2020-2025)
  12.7.1 China Point-of-care Molecular Diagnostic Solution Production Growth Rate (2020-2025)
  12.7.2 China Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2020-2025)

13 POINT-OF-CARE MOLECULAR DIAGNOSTIC SOLUTION MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Type (2020-2033)
13.3 Global Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2020-2033)
13.4 Global Point-of-care Molecular Diagnostic Solution Price by Type (2020-2033)

14 POINT-OF-CARE MOLECULAR DIAGNOSTIC SOLUTION MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Point-of-care Molecular Diagnostic Solution Market Sales by Application (2020-2033)
14.3 Global Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application (2020-2033)
14.4 Global Point-of-care Molecular Diagnostic Solution Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Abbott Laboratories
  15.1.1 Abbott Laboratories Basic Information
  15.1.2 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product Overview
  15.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.1.4 Abbott Laboratories Business Overview
  15.1.5 Abbott Laboratories SWOT Analysis
  15.1.6 Abbott Laboratories Recent Developments
15.2 F. Hoffmann-La Roche AG
  15.2.1 F. Hoffmann-La Roche AG Basic Information
  15.2.2 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product Overview
  15.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.2.4 F. Hoffmann-La Roche AG Business Overview
  15.2.5 F. Hoffmann-La Roche AG SWOT Analysis
  15.2.6 F. Hoffmann-La Roche AG Recent Developments
15.3 Becton
  15.3.1 Becton Basic Information
  15.3.2 Becton Point-of-care Molecular Diagnostic Solution Product Overview
  15.3.3 Becton Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.3.4 Becton Business Overview
  15.3.5 Becton SWOT Analysis
  15.3.6 Becton Recent Developments
15.4 Dickinson and Company
  15.4.1 Dickinson and Company Basic Information
  15.4.2 Dickinson and Company Point-of-care Molecular Diagnostic Solution Product Overview
  15.4.3 Dickinson and Company Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.4.4 Dickinson and Company Business Overview
  15.4.5 Dickinson and Company Recent Developments
15.5 BioMerieux
  15.5.1 BioMerieux Basic Information
  15.5.2 BioMerieux Point-of-care Molecular Diagnostic Solution Product Overview
  15.5.3 BioMerieux Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.5.4 BioMerieux Business Overview
  15.5.5 BioMerieux Recent Developments
15.6 Bio-Rad Laboratories
  15.6.1 Bio-Rad Laboratories Basic Information
  15.6.2 Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Product Overview
  15.6.3 Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.6.4 Bio-Rad Laboratories Business Overview
  15.6.5 Bio-Rad Laboratories Recent Developments
15.7 Inc.
  15.7.1 Inc. Basic Information
  15.7.2 Inc. Point-of-care Molecular Diagnostic Solution Product Overview
  15.7.3 Inc. Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.7.4 Inc. Business Overview
  15.7.5 Inc. Recent Developments
15.8 Cepheid
  15.8.1 Cepheid Basic Information
  15.8.2 Cepheid Point-of-care Molecular Diagnostic Solution Product Overview
  15.8.3 Cepheid Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.8.4 Cepheid Business Overview
  15.8.5 Cepheid Recent Developments
15.9 Inc.
  15.9.1 Inc. Basic Information
  15.9.2 Inc. Point-of-care Molecular Diagnostic Solution Product Overview
  15.9.3 Inc. Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.9.4 Inc. Business Overview
  15.9.5 Inc. Recent Developments
15.10 Danaher Corporation
  15.10.1 Danaher Corporation Basic Information
  15.10.2 Danaher Corporation Point-of-care Molecular Diagnostic Solution Product Overview
  15.10.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.10.4 Danaher Corporation Business Overview
  15.10.5 Danaher Corporation Recent Developments
15.11 Johnson and Johnson
  15.11.1 Johnson and Johnson Basic Information
  15.11.2 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product Overview
  15.11.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.11.4 Johnson and Johnson Business Overview
  15.11.5 Johnson and Johnson Recent Developments
15.12 Bayer Healthcare
  15.12.1 Bayer Healthcare Basic Information
  15.12.2 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product Overview
  15.12.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product Market Performance
  15.12.4 Bayer Healthcare Business Overview
  15.12.5 Bayer Healthcare Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Point-of-care Molecular Diagnostic Solution Market Size Comparison by Region (M USD)
Table 5. Global Point-of-care Molecular Diagnostic Solution Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Point-of-care Molecular Diagnostic Solution Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2024)
Table 10. Global Market Point-of-care Molecular Diagnostic Solution Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Point-of-care Molecular Diagnostic Solution Manufacturing Sites and Area Served
Table 12. Manufacturers Point-of-care Molecular Diagnostic Solution Product Type
Table 13. Global Point-of-care Molecular Diagnostic Solution Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Point-of-care Molecular Diagnostic Solution Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Point-of-care Molecular Diagnostic Solution Sales by Region (2020-2025) & (K Units)
Table 25. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Region (2020-2025)
Table 26. Global Point-of-care Molecular Diagnostic Solution Market Size by Region (2020-2025) & (M USD)
Table 27. Global Point-of-care Molecular Diagnostic Solution Market Size Market Share by Region (2020-2025)
Table 28. North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2033) & (M USD)
Table 29. North America Point-of-care Molecular Diagnostic Solution Sales by Country (2020-2033) & (K Units)
Table 30. North America Point-of-care Molecular Diagnostic Solution Sales by Type (K Units)
Table 31. North America Point-of-care Molecular Diagnostic Solution Market Size by Type (M USD)
Table 32. North America Point-of-care Molecular Diagnostic Solution Sales (K Units) by Type (2020-2033)
Table 33. North America Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type (2020-2033)
Table 34. North America Point-of-care Molecular Diagnostic Solution Sales by Application (K Units)
Table 35. North America Point-of-care Molecular Diagnostic Solution Market Size by Application (M USD)
Table 36. North America Point-of-care Molecular Diagnostic Solution Sales (K Units) by Application (2020-2033)
Table 37. North America Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application (2020-2033)
Table 38. Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2033) & (M USD)
Table 39. Europe Point-of-care Molecular Diagnostic Solution Sales by Country (2020-2033) & (K Units)
Table 40. Europe Point-of-care Molecular Diagnostic Solution Sales by Type (K Units)
Table 41. Europe Point-of-care Molecular Diagnostic Solution Market Size by Type (M USD)
Table 42. Europe Point-of-care Molecular Diagnostic Solution Sales (K Units) by Type (2020-2033)
Table 43. Europe Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type (2020-2033)
Table 44. Europe Point-of-care Molecular Diagnostic Solution Sales by Application (K Units)
Table 45. Europe Point-of-care Molecular Diagnostic Solution Market Size by Application (M USD)
Table 46. Europe Point-of-care Molecular Diagnostic Solution Sales (K Units) by Application (2020-2033)
Table 47. Europe Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application (2020-2033)
Table 48. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2025) & (M USD)
Table 49. Asia-Pacific Point-of-care Molecular Diagnostic Solution Sales by Country (2020-2025) & (K Units)
Table 50. Asia-Pacific Point-of-care Molecular Diagnostic Solution Sales by Type (K Units)
Table 51. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Type (M USD)
Table 52. Asia-Pacific Point-of-care Molecular Diagnostic Solution Sales (K Units) by Type (2020-2033)
Table 53. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type (2020-2025)
Table 54. Asia-Pacific Point-of-care Molecular Diagnostic Solution Sales by Application (K Units)
Table 55. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Application (M USD)
Table 56. Asia-Pacific Point-of-care Molecular Diagnostic Solution Sales (K Units) by Application (2020-2033)
Table 57. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application (2020-2025)
Table 58. South America Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2033) & (M USD)
Table 59. South America Point-of-care Molecular Diagnostic Solution Sales by Country (2020-2033) & (K Units)
Table 60. South America Point-of-care Molecular Diagnostic Solution Sales by Type (K Units)
Table 61. South America Point-of-care Molecular Diagnostic Solution Market Size by Type (M USD)
Table 62. South America Point-of-care Molecular Diagnostic Solution Sales (K Units) by Type (2020-2033)
Table 63. South America Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type (2020-2033)
Table 64. South America Point-of-care Molecular Diagnostic Solution Sales by Application (K Units)
Table 65. South America Point-of-care Molecular Diagnostic Solution Market Size by Application (M USD)
Table 66. South America Point-of-care Molecular Diagnostic Solution Sales (K Units) by Application (2020-2033)
Table 67. South America Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application (2020-2033)
Table 68. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2033) & (M USD)
Table 69. Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales by Country (2020-2033) & (K Units)
Table 70. Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales by Type (K Units)
Table 71. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Type (M USD)
Table 72. Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales (K Units) by Type (2020-2033)
Table 73. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type (2020-2033)
Table 74. Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales by Application (K Units)
Table 75. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size by Application (M USD)
Table 76. Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales (K Units) by Application (2020-2033)
Table 77. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application (2020-2033)
Table 78. Global Point-of-care Molecular Diagnostic Solution Production (K Units) by Region(2020-2025)
Table 79. Global Point-of-care Molecular Diagnostic Solution Revenue (US$ Million) by Region (2020-2025)
Table 80. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Region (2020-2025)
Table 81. Global Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. North America Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Europe Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Japan Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. China Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Global Point-of-care Molecular Diagnostic Solution Sales by Type (K Units)
Table 87. Global Point-of-care Molecular Diagnostic Solution Market Size by Type (M USD)
Table 88. Global Point-of-care Molecular Diagnostic Solution Sales (K Units) by Type (2020-2033)
Table 89. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Type (2020-2033)
Table 90. Global Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type (2020-2033)
Table 91. Global Point-of-care Molecular Diagnostic Solution Market Size Share by Type (2020-2033)
Table 92. Global Point-of-care Molecular Diagnostic Solution Sales (K Units) by Application
Table 93. Global Point-of-care Molecular Diagnostic Solution Market Size by Application(M USD)
Table 94. Global Point-of-care Molecular Diagnostic Solution Sales by Application (2020-2033) & (K Units)
Table 95. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Application (2020-2033)
Table 96. Global Point-of-care Molecular Diagnostic Solution Market Size by Application (2020-2033) & (M USD)
Table 97. Global Point-of-care Molecular Diagnostic Solution Market Share by Application (2020-2033)
Table 98. Global Point-of-care Molecular Diagnostic Solution Sales Growth Rate by Application (2020-2033)
Table 99. Abbott Laboratories Basic Information
Table 100. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product Overview
Table 101. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Abbott Laboratories Business Overview
Table 103. Abbott Laboratories SWOT Analysis
Table 104. Abbott Laboratories Recent Developments
Table 105. F. Hoffmann-La Roche AG Basic Information
Table 106. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product Overview
Table 107. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. F. Hoffmann-La Roche AG Business Overview
Table 109. F. Hoffmann-La Roche AG SWOT Analysis
Table 110. F. Hoffmann-La Roche AG Recent Developments
Table 111. Becton Basic Information
Table 112. Becton Point-of-care Molecular Diagnostic Solution Product Overview
Table 113. Becton Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Becton Business Overview
Table 115. Becton SWOT Analysis
Table 116. Becton Recent Developments
Table 117. Dickinson and Company Basic Information
Table 118. Dickinson and Company Point-of-care Molecular Diagnostic Solution Product Overview
Table 119. Dickinson and Company Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Dickinson and Company Business Overview
Table 121. Dickinson and Company Recent Developments
Table 122. BioMerieux Basic Information
Table 123. BioMerieux Point-of-care Molecular Diagnostic Solution Product Overview
Table 124. BioMerieux Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. BioMerieux Business Overview
Table 126. BioMerieux Recent Developments
Table 127. Bio-Rad Laboratories Basic Information
Table 128. Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Product Overview
Table 129. Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Bio-Rad Laboratories Business Overview
Table 131. Bio-Rad Laboratories Recent Developments
Table 132. Inc. Basic Information
Table 133. Inc. Point-of-care Molecular Diagnostic Solution Product Overview
Table 134. Inc. Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Inc. Business Overview
Table 136. Inc. Recent Developments
Table 137. Cepheid Basic Information
Table 138. Cepheid Point-of-care Molecular Diagnostic Solution Product Overview
Table 139. Cepheid Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Cepheid Business Overview
Table 141. Cepheid Recent Developments
Table 142. Inc. Basic Information
Table 143. Inc. Point-of-care Molecular Diagnostic Solution Product Overview
Table 144. Inc. Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Inc. Business Overview
Table 146. Inc. Recent Developments
Table 147. Danaher Corporation Basic Information
Table 148. Danaher Corporation Point-of-care Molecular Diagnostic Solution Product Overview
Table 149. Danaher Corporation Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Danaher Corporation Business Overview
Table 151. Danaher Corporation Recent Developments
Table 152. Johnson and Johnson Basic Information
Table 153. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product Overview
Table 154. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Johnson and Johnson Business Overview
Table 156. Johnson and Johnson Recent Developments
Table 157. Bayer Healthcare Basic Information
Table 158. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product Overview
Table 159. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 160. Bayer Healthcare Business Overview
Table 161. Bayer Healthcare Recent Developments
List of Figures
Figure 1. Product Picture of Point-of-care Molecular Diagnostic Solution
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Point-of-care Molecular Diagnostic Solution Market Size (M USD), 2024-2033
Figure 5. Global Point-of-care Molecular Diagnostic Solution Market Size (M USD) (2020-2033)
Figure 6. Global Point-of-care Molecular Diagnostic Solution Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Point-of-care Molecular Diagnostic Solution Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Point-of-care Molecular Diagnostic Solution Product Life Cycle
Figure 13. Point-of-care Molecular Diagnostic Solution Sales Share by Manufacturers in 2024
Figure 14. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Manufacturers in 2024
Figure 15. Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Point-of-care Molecular Diagnostic Solution Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Point-of-care Molecular Diagnostic Solution Revenue in 2024
Figure 18. Industry Chain Map of Point-of-care Molecular Diagnostic Solution
Figure 19. Global Point-of-care Molecular Diagnostic Solution Market PEST Analysis
Figure 20. Global Point-of-care Molecular Diagnostic Solution Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Region (2020-2025)
Figure 26. Global Point-of-care Molecular Diagnostic Solution Market Size Market Share by Region (2020-2025)
Figure 27. North American Market Snapshot
Figure 28. North America Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 29. North America Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. North America Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Country
Figure 31. USA Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 32. USA Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. Canada Point-of-care Molecular Diagnostic Solution Sales (K Units) and Growth Rate (2020-2033)
Figure 34. Canada Point-of-care Molecular Diagnostic Solution Market Size (M USD) and Growth Rate (2020-2033)
Figure 35. Mexico Point-of-care Molecular Diagnostic Solution Sales (Units) and Growth Rate (2020-2033)
Figure 36. Mexico Point-of-care Molecular Diagnostic Solution Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. North America Point-of-care Molecular Diagnostic Solution Market Size (M USD)by Type
Figure 38. North America Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application
Figure 39. Europe Market Snapshot
Figure 40. Europe Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 41. Europe Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 42. Europe Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Country
Figure 43. Germany Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 44. Germany Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 45. France Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. France Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. U.K. Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. U.K. Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 49. Italy Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. Italy Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 51. Spain Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Spain Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Europe Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type
Figure 54. Europe Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application
Figure 55. Asia-Pacific Market Snapshot
Figure 56. Asia-Pacific Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 57. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Country
Figure 59. China Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. China Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Japan Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Japan Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. South Korea Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. South Korea Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. India Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. India Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. Southeast Asia Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. Southeast Asia Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type
Figure 70. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application
Figure 71. South America Market Snapshot
Figure 72. South America Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 73. South America Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 74. South America Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Country
Figure 75. Brazil Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 76. Brazil Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 77. Argentina Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Argentina Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Columbia Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Columbia Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. South America Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type
Figure 82. South America Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application
Figure 83. Middle East and Africa Market Snapshot
Figure 84. Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 85. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 86. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Country
Figure 87. Saudi Arabia Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 88. Saudi Arabia Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 89. UAE Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. UAE Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. Egypt Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. Egypt Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Nigeria Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Nigeria Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. South Africa Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. South Africa Point-of-care Molecular Diagnostic Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type
Figure 98. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application
Figure 99. Global Point-of-care Molecular Diagnostic Solution Production Market Share by Region (2020-2025)
Figure 100. North America Point-of-care Molecular Diagnostic Solution Production (K Units) Growth Rate (2020-2025)
Figure 101. Europe Point-of-care Molecular Diagnostic Solution Production (K Units) Growth Rate (2020-2025)
Figure 102. Japan Point-of-care Molecular Diagnostic Solution Production (K Units) Growth Rate (2020-2025)
Figure 103. China Point-of-care Molecular Diagnostic Solution Production (K Units) Growth Rate (2020-2025)
Figure 104. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 105. Global Point-of-care Molecular Diagnostic Solution Market Size by Type (M USD)
Figure 106. Sales Market Share of Point-of-care Molecular Diagnostic Solution by Type (2020-2033)
Figure 107. Sales Market Share of Point-of-care Molecular Diagnostic Solution by Type in 2024
Figure 108. Market Size Share of Point-of-care Molecular Diagnostic Solution by Type (2020-2033)
Figure 109. Market Size Share of Point-of-care Molecular Diagnostic Solution by Type in 2024
Figure 110. Global Point-of-care Molecular Diagnostic Solution Price (USD/Unit) by Type (2020-2033)
Figure 111. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 112. Global Point-of-care Molecular Diagnostic Solution Market Size by Application(M USD)
Figure 113. Global Point-of-care Molecular Diagnostic Solution Market Share by Application
Figure 114. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Application (2020-2033)
Figure 115. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Application in 2024
Figure 116. Global Point-of-care Molecular Diagnostic Solution Market Share by Application (2020-2033)
Figure 117. Global Point-of-care Molecular Diagnostic Solution Market Share by Application in 2024
Figure 118. Global Point-of-care Molecular Diagnostic Solution Sales Growth Rate by Application (2020-2033)